N 6 -methyladenosine (m 6 A) is the most common reversible internal modification in mammalian RNA. Changes in m 6 A levels have been implicated in a variety of cellular processes, including nuclear RNA export, control of protein translation, and protein splicing, and they have been linked to obesity, cancer, and other human diseases. METTL3 and METTL14 are N 6 -adenosine methyltransferases that work more efficiently in a stable METTL3-METTL14 heterodimer complex (METTL3-14). ALKBH5 is an m 6 A-RNA demethylase that belongs to the AlkB family of dioxygenases. We report the development of radioactivity-based assays for kinetic characterization of m 6 A-RNA modifications by METTL3-14 complex and ALKBH5 and provide optimal assay conditions suitable for screening for ligands in a 384-well format with Z′ factors of 0.78 and 0.77, respectively.
Introduction
RNA methylation at the N 6 position on adenine (m 6 A) was originally identified in the 1970s, [1] [2] [3] and was shown to be one of the most abundant internal mRNA modifications. 4 These initial reports showed that approximately 0.1% to 0.4% of the adenosines in cellular RNA are m 6 A modified. 4 The m 6 A modification has been identified in many species including viruses, plants, yeast, mammals, and flies (reviewed in refs. 5 and 6). Furthermore, m 6 A modification has been shown to occur on many RNAs including noncoding, ribosomal, and polyadenylated. 5 In eukaryotic cells, m 6 A accounts for more than 80% of all RNA methylation. 7 The m 6 A modification on mRNA mainly occurs on exonic regions along with 3′-untranslated regions (3′-UTR) and tends to mark unstable transcripts. 7, 8 It has been reported that for a large number of transcripts in mouse embryonic stem cell (mESCs), m 6 A methylation inversely correlates with mRNA stability and gene expression. 9 Beyond mESC development, m 6 A modification has been linked to many physiological processes such as synaptic signaling, cancer, sperm development, yeast meiosis, plant development, RNA splicing, and circadian periods. 5, [9] [10] [11] [12] [13] [14] [15] Not surprising given the many correlations of m 6 A and physiological processes, m 6 A methylation levels vary in different tissues and cell lines with higher enrichment in liver, kidney, and brain. 4 METTL3 (methyltransferase like 3) and METTL14 (methyltransferase like 14) catalyze m 6 A methylation (Scheme 1). These two enzymes with 43% amino acid identity recognize the GGACU sequence on mammalian nuclear RNA. 16 METTL3 and METTL14 form a stable heterodimer complex that functions to drive m 6 A methylation more efficiently than either enzyme does individually. 16 Although the heterodimer formation greatly increases the enzymatic activity of METTL3-14, two other binding partners have been recently identified. The binding of Wilms tumor 1-associating protein (WTAP) and KIAA1429 to the heterodimer complex further simulate the enzymatic activity. WTAP appears to greatly increase the binding affinity of METTL3 for RNA. 17, 18 However, WTAP is not needed for the heterodimer activity in vitro, and its presence appears to affect which m 6 A sites can be specifically methylated, suggesting WTAP-dependent and -independent methylation sites. 18 WTAP is also responsible for the localization of METTL3 and METTL14 to nuclear speckles enriched with pre-mRNA processing factors and for catalytic activity of the m 6 A methyltransferase in vivo. 17 Loss of m 6 A has been reported to promote self-renewal and hinder differentiation of mouse embryonic stem cells. 8 However, depletion of METTL3 and METTL14 in HeLa cells led to decreased cell viability and apoptosis. 16 Similar to other methylation marks, mRNA methylation can be reversed through the enzymatic activity of demethylases (Scheme 1). Demethylation of the m 6 A mark is carried out by fat mass and obesity protein (FTO) and ALKBH5, both of which belong to the ALKB family that includes ALKBH1-8 and FTO. 11, 19, 20 Both FTO and ALKBH5 are Fe(II)-and 2-oxoglutarate (2-OG)-dependent enzymes that remove m 6 A marks through an oxidative process. 21 Knockdown of ALKBH5 was shown to affect splicing in tissue culture cells and displayed a sterility phenotype in male mice. 11 FTO has been linked to obesity and type 2 diabetes. 22, 23 Specifically, loss of FTO in mice has been linked to a reduction in adipose tissue, decreased lean body mass, and postnatal growth retardation, 24 whereas Alkbh5-deficient mice have impaired fertility, a result of apoptosis during spermatocyte formation. 11 FTO and ALKBH5 are the only two m 6 A-RNA demethylases identified to-date.
Methyltransferase activity of METTL3-14 complex and demethylase activity of ALKBH5 have been previously reported. 11, 16, 25 Here, we used a radioactivity-based assay to fully characterize the m 6 A methyltransferase activity of the METTL3-14 complex and used this complex to prepare the 3 H-m 6 A RNA substrate to further characterize ALKBH5 activity. We further optimized these assays for screening in a 384-well format, which enables discovery of inhibitors for these key enzymes in the maintenance of m 6 A mark.
Materials and Methods
Iron (II) sulfate (cat. No. F7002), 2-OG (cat. No. K1875), ascorbic acid (cat. No. A5960), S-(5′-adenosyl)-Lmethionine (SAM; cat. No, NET155V250UC), and S-adenosylhomocysteine (SAH; cat. No. A9384) were purchased from Sigma. 3 H-SAM and a 384-well FlashPlate coated with streptavidin (cat. No. SMP410A001PK) were purchased from Perkin Elmer. Biotin-labeled single-strand RNA (ss-RNA; sequence: 5′-UACACUCGAUCUGGACUAAAGCU GCUC-biotin-3′) was ordered from Integrated DNA Technologies. The biotinylated RNA was about 90% pure according to quality control documents provided along with the product.
Protein Expression and Purification
The METTL3 and METTL14 clones were kindly provided by Dr. Chuan He (University of Chicago). The expression and purification were carried out as previously reported with some modifications. 16 The FLAG-tagged constructs were expressed by using Expi293 cells. The recombinant protein complex was purified by incubating the cleared lysate with equilibrated anti-FLAG M2 affinity agarose gel (Sigma, cat. No. A2220) for 1.5 h rotating, followed by washing with 10 CV TBS (50 mM Tris-HCl pH 7.4, 150 mM NaCl, and 10% glycerol). The recombinant protein complex was eluted by competitive elution with a solution containing 100 µg/mL FLAG peptide (Sigma, cat. No. F4799) in TBS, 1 mM dithiothreitol (DTT), and 10% glycerol. The purity of the complex was judged by sodium dodecyl sulfate polyacrylamide gel electrophoresis (Suppl. Fig. S1 ). The protein complex was concentrated and flash frozen.
The ALKBH5 gene (amino acids 74 to 294) was expressed in Escherichia coli BL21 (DE3) V2R-pRARE and purified by DE52 and Ni-NTA columns (Qiagen) as previously described. 19, 26 Briefly, the lysate was passed through a DE52 column at 500 mM NaCl to filter DNA and other nonprotein contaminants followed by the Ni-NTA column. Resin was washed with binding buffer (20 mM Tris, pH 7.5, 500 mM NaCl, 5% glycerol, and 5 mM imidazole) followed by washing with wash buffer (binding buffer with 30 mM imidazole) and eluted with elution buffer (binding buffer with 250 mM imidazole). The His-tag was cleaved overnight with pTEV, while dialyzing in 10 mM Tris-HCl pH 7.5, 150 mM NaCl, followed by passing the sample through a second Ni-NTA column to filter the free tags out. Cut protein was then loaded onto a SuperDex 200 (26/60) column using AktaExplorer in 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT. After pooling selected fractions, ALKBH5 was then subjected to ion exchange using AktaFPLC, on a 1 mL Resource S column. Pure protein was eluted around 220 mM NaCl and was pooled, concentrated, aliquoted, and flash frozen (Suppl. Fig. S2 ).
METTL3-14 Assay
The methyltransferase activity of METTL3-14 complex was measured using a radioactivity-based assay. In this assay, tritiated S-adenosyl-L-methionine ( 
ALKBH5 Assay
The ALKBH5 substrate, m 6 A-ss-RNA (5′-UACACUCGA UCUGG(m 6 A)CUAAAGCUGCUC-3′-biotin) was generated using the METTL3-14 complex to completely monomethylate N 6 A ss-RNA. Of the METTL3-14, 500 nM was incubated with 5 µM of biotin-labeled ss-RNA and 5 µM of 3 H-SAM in 20 mM Tris-HCl pH 7.5, 1 mM DTT, 0.01% Triton X-100, 40 U of RNaseOUT/100 µL buffer for 1 h at 23 °C. Then, the reaction mixture was heat shocked at 85 °C for 15 min to denature the methyltransferase METTL3-14 complex, after which the sample was left on ice to cool down. To determine the kinetic parameters, the demethylase assays were performed in 25 nM ALKBH5, 10 µM 2-OG, 100 µM ascorbate, 20 µM Fe (II), and varying concentrations of monomethylated ss-RNA. An equal volume of 7.5 M guanidine-HCl was used to quench ALKBH5 activity after 1 h reaction at 37 °C. Sixty microliters of 20 mM Tris-HCl, pH 8.0, was added into the quenched wells. The quenched reaction mixtures were transferred to a streptavidin/scintillant-coated microplate (FlashPlate Plus, Perkin Elmer Life Sciences), allowed to bind for at least 1 h, and then the decrease of radioactive signals was detected on a Top-Count NXT HTS (Perkin Elmer).
Z′ Factor Determinations
To assess the quality of METTL3-14 or ALKBH5 assays for screening in a 384-well format, Z′ factors 27 were determined. In these assays, the reactions were run in 8 complete rows (half plate) with or without a known inhibitor. SAH was used as an inhibitor for METTL3-14, and IOX1 (A broad-spectrum inhibitor of most 2-OG oxygenases) was used for ALKBH5. The Z′ factors were calculated as described by Zhang et al. 27 
Results
Methylation of N 6 -adenine on ss-RNA (m 6 A) is a reversible modification that is maintained by methyltransferase activity of METTL3 and METTL14 16 and demethylase activity of ALKBH5 and FTO (Scheme 1). 11, 28 Their roles in diverse biological processes and possible disease associations necessitate developing robust assays to enable screening with higher throughput to discover potent and selective inhibitors that could be used to further study the consequences of changes in their activities in cells. We chose to develop radioactivitybased assays for both the METTL3-14 complex and ALKBH5, which are amenable to screening in a 384-well format and suitable for kinetic characterizations.
Similar to the histone methylatransferase activity assays we previously reported, 29 the mRNA methyltransferase activity of the METTL3-14 complex was assayed by measurement of the enzymatic transfer of tritiated methyl groups from 3 H-SAM to an N 6 of adenine in ss-RNA (m 6 A). We then used the METTL3-14 complex at an optimized condition to generate m 6 A-ss-RNA (methylated) substrate to assay ALKBH5. ALKBH5 activity was measured by monitoring the removal of a 3 H-methyl group from m 6 A-ss-RNA (Scheme 1).
Assay Optimization for METTL3-14 Complex
It was previously shown that METTL3 and METTL14 form a stable active complex. 16 Using 3 H-SAM and ss-RNA, we were able to monitor m 6 A-ss-RNA production and tested the activity of the complex with respect to reducing agents ( Fig. 1A) , KCl (Fig. 1B) , NaCl (Fig. 1C) , MgCl 2, (Fig. 1D) , Triton X-100 ( Fig. 1E) , EDTA (Fig. 1F) , DMSO (Fig. 1G) , glycerol (Fig. 1H) , and buffer pH (Fig. 1I) . The complex was most active at pH 7.5. Reducing agents DTT and Tris (2-carboxyethyl) phosphine (TCEP) are widely used to keep enzymes active. Conversely, the addition of DTT or TCEP dramatically inhibited the activity of METTL3-14 in a concentration-dependent manner (Fig. 1A) . We tried to avoid reducing agents; however, it was essential to use the RNase inhibitor (RNaseOUT) in the assay mixture, which requires the presence of DTT to function. Therefore, we kept the DTT at low concentration (≦1 mM). The ionic strength of the buffer also significantly affected METTL3-14 activity. The enzyme activity was inhibited as the ionic strength increased, inactivating the protein complex at 100 mM of KCl (Fig. 1B) or NaCl (Fig. 1C ) and 1 mM of MgCl 2 (Fig.  1D) . Triton X-100 (up to 1%), EDTA (up to 1 mM), and glycerol (up to 5%) had no significant effect on METTL3-14 complex activity (Fig. 1E, F, and H) . DMSO as high as 5% had little effect on the activity of the complex (Fig. 1G) .
Based on these observations, the optimal assay condition (20 mM Tris-HCl, pH 7.5, 0.01% Triton X-100, 1 mM DTT, and 40 U RNaseOUT/100 µL) was used for all kinetic parameter determination experiments.
Kinetic Parameters for METTL3-14 Complex
Using the optimized assay conditions, the kinetic parameters were determined for the METTL3-14 complex with ss-RNA substrate containing a consensus sequence of GGACU (K m values of 102 ± 15 nM and 22 ± 2 nM for SAM and ss-RNA, respectively, and k cat value of 18 ± 2 h -1 ; Table 1 ). The catalytic efficiency (k cat /K m ) of the METTL3-14 complex was 818 h -1 µM -1 (Table 1; Fig. 2A, B) . SAH showed strong inhibitory effects on METTL3-14 activity with an IC 50 value of 0.9 ± 0.1 µM (Fig. 2C) . The quality of the high-throughput screen (HTS) was examined, and the Z′ factor of 0.78 (Fig. 2D) for screening in a 384-well format was obtained, indicating that this assay is very suitable for HTS.
Assay Optimization for ALKBH5 m 6 A-ss-RNA demethylase activity of ALKBH5 is essential to regulate the level of m 6 A modification for normal functions. To develop a radioactivity-based activity assay for ALKBH5, we needed a 3 H-m 6 A-ss-RNA substrate that was not commercially available. We therefore employed our optimized METTL3-14 assay to generate 3 H-m 6 A-ss-RNA using biotinylated ss-RNA and 3 H-SAM. The efficiency of methylation of ss-RNA was evaluated using the commercially available 3 H-biotin, indicating that 5 µM of biotinylated ss-RNA was completely methylated in 1 h by using 250 nM of METTL3-14 complex (Suppl. Fig. S3) . The 3 H-monomethylated ss-RNA ( 3 H-m 6 A-ss-RNA) was then used as a substrate for ALKBH5, as described in the Materials and Methods section. In this assay, the decrease in radioactive signal (CPM) reflects the 3 H-m 6 A-ss-RNA demethylation by ALKBH5. In the absence of the enzyme, any reduction in CPM in each data set was defined as background. Similar to METTL3-14, the higher the concentration of reducing agents DTT or TCEP, the less active ALKBH5 was (Fig. 3A) . In contrast, the presence of SAH, NaCl, MgCl 2 , DMSO, and Triton X-100 ( Fig. 3B-F) had no significant effects on ALKBH5 activity. The optimum pH was 7 to 7.5 (Fig. 3G) . ALKBH5 activity was ferrous iron dependent ( Fig. 3H) , which was further activated by low concentrations of ascorbate (Fig. 3I) .
Kinetic Parameters for ALKBH5
Optimized assay conditions (20 mM Tris-HCl pH 7.0, 100 µM ascorbate, 20 µM Fe[II], 0.01% Triton X-100) were used for determination of kinetic parameters for ALKBH5 ( Table 1) . The K m values were 2.5 ± 0.5 µM and 192 ± 25 nM ( Fig. 4A, B ) for 2-OG and m 6 A-ss-RNA, respectively, and the k cat value was 18 ± 4 h -1 . IOX1, a broad-spectrum 2-OG oxygenase inhibitor, also inhibited ALKBH5 activity in a cofactor 2-OG competitive manner, with IC 50 values of 0.5 ± 0.1 µM, 1.8 ± 0.5 µM, and 2.9 ± 0.3 µM at 2 µM, 5 µM, and 20 µM of 2-OG, respectively (Fig. 4C) . The optimized assay was suitable for screening in a 384-well format with a Z′ factor of 0.77 (Fig. 4D) .
Discussion
Although the m 6 A mark on RNA was reported many years ago, 1-3 recent progress in the discovery of components of methyltransferase complex responsible for methylation of N 6adenine on RNA, 16,17 m 6 A-RNA readers, 13 and two m 6 A-RNA demethylases, FTO 20 and ALKBH5, 11, 28 created greater interest in investigating the roles that this reversible m 6 A-RNA modification plays in cells. Increasing evidence shows that m 6 A in mRNA affects mRNA splicing, trafficking, translation, and stability; thus, the reversible m 6 A modification in mRNA plays broad and critical roles in fundamental biological processes and disease development. 5, 30 METTL3 and METTL14 methyltransferase activities have been examined using mass spectrometry-based assays, which indicated that they form a stable heterodimer that is more active than each component individually. 16 Similar methods have also been used to assay demethylases. 11 A radioactivity-based cell assay was also used by tracing the mRNA modifications through analyzing the composition of the methyl-labeled nucleosides. 1 Discovery of potent and selective inhibitors of METTL3-14, ALKBH5, and FTO would be important for studying the consequences associated with the dysregulation of their activities and the m 6 A-RNA mark in cells. The natural product rhein was reported as an inhibitor of FTO with an IC 50 value of 30 µM using m 6 A-containing 15-mer ss-RNA as substrate and a high-performance liquid chromatography (HPLC)-based assay. 31 Huang et al. 32 identified meclofenamic acid (MA) as a highly selective inhibitor of FTO (IC 50 : 8 µM) over ALKBH5 (no inhibition) using HPLC-based assays. 32 They also used a fluorescence polarization-based assay to test the displacement of ssDNA by MA. In this study, we reported on the full kinetic characterization of the METTL3-14 complex and the development of a radioactivity-based assay that is suitable for screening in a 384-well format. We also used the METTL3-14 complex to generate m 6 A-RNA substrate for ALKBH5 to determine its kinetic parameters and optimize a 384-well format screening assay. The kinetic parameters we reported here for ALKBH5 are comparable with those reported by He's lab. 11 These assays can be used in screening large libraries of compounds in a 384-well format, which could have a higher throughput in comparison with mass spectrometry-based or HPLC-based assays. Radioactivity-based assays typically have fewer false-positives compared with fluorescence-based assays and are less laborious compared with mass spectrometry-based assays. Even in our academic setting, these assays allow for the screening of 4000 compounds per person per day. The kinetic parameters provided in this study as well as the highly reproducible assays pave the way to higher-throughput screening RNAme1; B) . IOX1 inhibited ALKBH5 activity with IC 50 values of 0.5 ± 0.1 µM, 1.8 ± 0.5 µM, and 2.9 ± 0.3 µM at 2 (), 5 (), and 20 µM () of 2-OG, respectively (C). Z′ factor (0.77) was determined in the absence (gray spots) and presence (black spots) of 100 µM of IOX1 using 10 µM 2-OG and 200 nM ss-RNAme1 in 20 mM Tris-HCl pH 7, 0.01% Triton X-100, 100 µM ascorbate, and 20 µM Fe 2+ (D). Experiments were performed in triplicate.
